Proactive Investors - Run By Investors For Investors

Futura Medical highlights "huge interest" for erectile dysfunction gel based on Ipsos research

James Barder, chief executive officer at Futura Medical (LON:FUM) discusses the Ipsos findings that show its treatment for erectile dysfunction has the potential to be a US$1bn drug.

Meet Premier African Minerals Ltd, Anglo Asian Mining Plc and Thor Mining PLC at our event, London, 21 September 2017. Register here »
View full FUM profile View Profile

Futura Medical plc. Timeline

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use